Psychiatric conditions share common genes, but mechanisms that differentiate diagnoses remain unclear. We present a multidimensional framework for functional analysis of rare copy number variants (CNVs) across 6 diagnostic categories, including schizophrenia (SCZ), autism (ASD), bipolar disorder (BD), depression (MDD), PTSD, and ADHD (N = 574,965). Using gene-set burden analysis (GSBA), we tested duplication (DUP) and deletion (DEL) burden across 2,645 functional gene sets defined by the intersections of pathways, cell types, and cortical regions. While diagnoses converge on shared pathways, mixed-effects modeling revealed divergence of pathway effects by cell type, brain region, and gene dosage. Factor analysis identified latent dimensions aligned with clinical axes. A primary factor (F1) captured reciprocal dose-dependent effects of DUP and DEL in SCZ reflecting positive and negative effects in excitatory versus inhibitory neurons and association versus sensory cortex. SCZ and ASD were both strongly aligned with F1 but with opposing directionalities. Orthogonal factors highlighted neuronal versus non-neuronal effects in mood disorders (F2) and differential spatial distributions of DEL effects in ADHD and MDD (F3). High-impact CNVs at 16p11.2 and 22q11.2 were enriched for combinations of cell-type-specific genes involved in pathways consistent with our broader findings. These results reveal molecular and cellular mechanisms that are broadly shared across psychiatric traits but differ between diagnostic categories in context and directionality.
Compound heterozygous events involving a chromosome deletion and on the remaining allele a functional DNA sequence-level variant can underpin a range of medical conditions. Most large-scale genetic studies do not include a systematic analysis of such compound heterozygous deletion (DelCH) events. We developed three frameworks: i) traditional burden analysis; ii) deletion-matched burden analysis; and iii) transmission disequilibrium test (TDT), to examine the possible contribution of DelCH to clinical presentations, and report results of their implementation in 9,766 families of autistic individuals. Across the three strategies, we observed enrichment of rare DelCH events in autistic individuals at a nominal significance level for individual tests. Collectively, six genes; CFHR4 , HSDL1 , MYO15A , NEFH , and three olfactory receptor genes; OR1A2 , OR4P2 , were affected by DelCH events in at least two unrelated autistic individuals (and not in unaffected family members), while the reverse analyses identified no genes (p<2.2 x 10 -16 ). Gene set enrichment analysis of the extended network of candidate genes showing a remarkable convergence to processes related to neurogenesis. Our findings suggest a modest role for DelCH events in ASD. The strategies described here are available via a GitHub repository, allowing the research community to examine the role of DelCH in other genome sequencing cohorts.